Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11406616
Lipids with odd number of carbon atoms and their use as pharmaceutical composition or nutritional supplement
granted -
US 11407998
Twist signaling inhibitor compositions and methods of using the same
granted -
US 11406656
Methods and compositions for administration of iron
granted -
US 11407990
Fusion proteins and methods for site-directed genome editing
granted -
US 11407984
Methods for purification of arysulfatase A
granted -
US 11407997
Materials and methods for treatment of primary hyperoxaluria type 1 (PH1) and other alanine-glyoxylate aminotransferase (AGXT) gene related conditions or disorders
granted -
US 11407764
AhR modulators
granted -
US 11407723
Selective histone deacetylase inhibitors for the treatment of human disease
granted -
US 11407813
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11408001
Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof
granted -
US 11407818
Antibodies that bind to dengue virus serotype 4 (DENV4) and methods of making and using the same
granted -
US 11407759
Solid forms of 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione
granted -
US 11407789
Cell-penetrating compstatin analogs and uses thereof
granted -
US 11407747
Compositions and methods for inhibiting kinases
granted -
US 11407736
RIP1 inhibitory compounds and methods for making and using the same
granted -
US 11407748
Substituted pyrido[1,2-a]pyrimidines and pyrazino[1,2-a]pyrimidines for enhancing AMPA receptor function
granted -
US 11407752
Substituted 4,6-dihydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3′-indoline]-2′,5(3H)-dione analogues
granted -
US 11407820
Modulating the alternative complement pathway
granted -
US 11406643
Targeting kinases for the treatment of cancer metastasis
granted -
US 11407800
Translatable molecules and synthesis thereof
granted -
US 11406724
Stabilized radiolabeled anti-CD45 immunoglobulin compositions
granted -
US 11407825
NaPi2b-targeted polymer antibody-drug conjugates and methods of use thereof
granted -
US 11407712
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α
granted -
CA 3206564
PROCEDES ET COMPOSITIONS NUTRITIONNELLES PERMETTANT D'AMELIORER LA PRODUCTION D'ENERGIE MUSCULAIRE ET/OU LA FORCE MUSCULAIRE
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.